Can you provide the last earnings date for TABULA RASA HEALTHCARE INC?
TABULA RASA HEALTHCARE INC (TRHC) last reported earnings on 11/7/2023.
NASDAQ:TRHC • US8733791011
Past quarterly earnings results for TABULA RASA HEALTHCARE INC (TRHC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 0.03 | -0.12 | 125.03% | 112.00% | 90.036M | 90.648M | -0.68% | 24.02% |
| Q1 2023 | -0.02 | -0.14 | 85.99% | 90.91% | 88.277M | 85.662M | 3.05% | 31.54% |
| Q4 2022 | -0.05 | -0.07 | 24.59% | 44.44% | 82.708M | 82.478M | 0.28% | 20.05% |
| Q3 2022 | -0.26 | -0.11 | -127.59% | -550.00% | 77.101M | 75.497M | 2.12% | 13.53% |
| Q2 2022 | -0.25 | -0.12 | -107.71% | -2,400.00% | 72.597M | 69.678M | 4.19% | 12.91% |
| Q1 2022 | -0.22 | -0.16 | -37.26% | -144.44% | 67.11M | 86.582M | -22.49% | -12.48% |
| Q4 2021 | -0.09 | -0.08 | -12.04% | -12.50% | 68.897M | 86.892M | -20.71% | -10.58% |
| Q3 2021 | -0.04 | 0.03 | -216.19% | -300.00% | 67.91M | 90.292M | -24.79% | -3.69% |
| Q2 2021 | -0.01 | 0.00 | -194.41% | -114.29% | 64.297M | 83.315M | -22.83% | -16.31% |
| Q1 2021 | -0.09 | -0.09 | 4.32% | -1,000.00% | 76.68M | 77.674M | -1.28% | 5.29% |
| Q4 2020 | -0.08 | -0.10 | 18.87% | - | 77.05M | 76.394M | 0.86% | - |
| Q3 2020 | -0.01 | 0.04 | -123.44% | - | 70.51M | 77.322M | -8.81% | - |
| Q2 2020 | 0.07 | 0.06 | 22.92% | - | 76.83M | 79.65M | -3.54% | - |
| Q1 2020 | 0.01 | -0.05 | 120.42% | - | 72.83M | 73.194M | -0.50% | - |
Notes
TABULA RASA HEALTHCARE INC (TRHC) last reported earnings on 11/7/2023.
TABULA RASA HEALTHCARE INC (TRHC) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, TABULA RASA HEALTHCARE INC (TRHC) has beaten EPS estimates in 3 out of 4 releases.